Eocene Ltd EOCN

$1.78 +0.03 (1.73%)

Valuation

Market cap
1,854,000
Revenue TTM
$0
Net income TTM
$-10,310,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
9,100
Avg volume
8,966
Day's range
$1.78 – $1.96
Shares out
1,042,000
Stochastic %K
3%
Beta
0.70
Analysts
—
Price target
—

Price

Company profile

Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes melli...

Show more

Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through the ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company is developing MyBiotics, which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform and Tissue Dynamics to develop a novel human chronic cardiac fibrosis model. Eocene Ltd. was formerly known as Galmed Pharmaceuticals Ltd. and changed its name to Eocene Ltd. in September 2026. Eocene Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 3 693 8448
Website
https://eocn.com
Address
16 Abba Hillel Road, Ramat Gan, Israel

Latest news

Stocktwits

Lowlyme Nov 20, 10:34 PM
$EOCN A buck eighty. Good grief.
0 replies
Lowlyme Nov 20, 11:04 AM 1 replies
Lowlyme Nov 20, 11:00 AM
$EOCN POOF!
0 replies
ka1954 Nov 19, 9:02 PM
$EOCN so selling due to market downturn, but no buying due to market upturns ?
0 replies
Lowlyme Nov 19, 6:44 PM
$EOCN Which is now happening every few months.
2 replies
madan_shatri Nov 19, 6:44 PM
$EOCN After spending 20 years in stock market. 1st time ever I dound myself in such a worst type of open ended scam. I played many good & bad stocks, but never had this type of scam. At moment this never looked like a real stock. Past 5 yrs a consistent decline except one odd day in (I think year 2024). In last 1500 trading days, this stock is kind of declining almosf every day except one day when i rose to $23.X from $3.00 in single day. Thats it. What a freak scam. Every single day, never ever looked like its wanna go up, every single day decline. But relieved now. Although took loss but better than yesterday
0 replies
madan_shatri Nov 19, 5:51 PM
$EOCN under $1.00 before year end.
0 replies
ka1954 Nov 19, 5:46 PM
$EOCN this stock has one of the lowest volume of any stock !!! this proves that a stock can just keep going down until next RS
1 replies